A mobile app to help lower sodium intake and blood pressure in people with hypertension
A Just-In-Time Adaptive Mobile Application Intervention To Reduce Sodium Intake And Blood Pressure In Hypertensive Patients
This study is testing a friendly mobile app designed to help people with high blood pressure eat less salt by sending helpful tips and reminders when they're at home or out shopping and dining, making it easier to stick to a healthier diet.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11183295 on NIH RePORTER |
What this research studies
This research develops a mobile application that provides personalized support to help individuals with hypertension reduce their sodium intake. By using geofencing technology, the app sends tailored notifications when users are at home, grocery stores, or restaurants, guiding them towards healthier food choices. The goal is to promote long-term adherence to a low-sodium diet, which is crucial for managing blood pressure and preventing cardiovascular diseases. Participants will receive real-time information and encouragement to make healthier dietary decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with hypertension who are looking to manage their condition through dietary changes.
Not a fit: Patients who do not have hypertension or those who are unable to use mobile technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in sodium intake and blood pressure for patients with hypertension.
How similar studies have performed: Previous studies have shown promise in using mobile applications for dietary management, indicating potential for success with this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Dorsch, Michael — University of Michigan at Ann Arbor
- Study coordinator: Dorsch, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.